Evidence map›Paper›PMID 37113757›Full record

ArticleFrontiers in pharmacology2023

The effect of CFTR modulators on structural lung disease in cystic fibrosis.

L Clara Mok, Antonio Garcia-Uceda, Matthew N Cooper, Mariette Kemner-Van De Corput, Marleen De Bruijne, Nathalie Feyaerts, Tim Rosenow, Kris De Boeck, Stephen Stick, Harm A W M Tiddens

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

L Clara MokFaculty of Medicine and Health Sciences, The University of Western Australia, Perth, WA, Australia.
Antonio Garcia-UcedaDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Matthew N CooperTelethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.
Mariette Kemner-Van De CorputDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Marleen De BruijneDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Nathalie FeyaertsDepartment of Pediatric Pulmonology, University of Leuven, Leuven, Belgium.
Tim RosenowFaculty of Medicine and Health Sciences, The University of Western Australia, Perth, WA, Australia.
Kris De BoeckDepartment of Pediatric Pulmonology, University of Leuven, Leuven, Belgium.
Stephen StickFaculty of Medicine and Health Sciences, The University of Western Australia, Perth, WA, Australia.
Harm A W M TiddensDepartment of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Erasmus MC · NLUniversity of Western Australia · AUKU Leuven · BEThe Kids Research Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CFTR modulatorchest CTcystic fibrosisquantitative measuresstructural lung disease

Identifiers

PMID37113757
PMCPMC10127680
OpenAlexW4364357737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.